Advertisement

Topics

Receptor BioLogix, Inc. Company Profile

13:12 EST 16th December 2018 | BioPortfolio

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.

Location

1140 Veterans Boulevard, Suite A
South San Francisco
California
94080
United States of America

Contact

Phone: (650) 266-4600
Fax: (650) 952-2205
Email: info@rblx.com


News Articles [470 Associated News Articles listed on BioPortfolio]

Viewing serotonin activating its receptor for the first time

A team of researchers have used high-powered microscopes to view serotonin activating its receptor for the first time. Images reveal molecular details about the receptor that could improve drug design...

Hidden estrogen receptors in breast epithelium

Scientists have uncovered that next to estrogen receptor positive and negative there are cells with very low amounts of the receptor protein. The discovery has significant implications for the role of...

Receptor structure could be key to developing new osteoporosis drugs

Researchers at the University of Zurich have determined the three-dimensional structure of a receptor that controls the release of calcium from bones. The receptor is now one of the main candidates fo...

Hidden estrogen receptors in the breast epithelium

(Ecole Polytechnique Fédérale de Lausanne) EPFL scientists have uncovered that next to estrogen receptor positive and negative there are cells with very low amounts of the receptor protein. The disc...

EASD 2018: the struggles of GSK’s GLP-1 receptor agonist

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent a type 2 diabetes (T2D) injectable drug class that is increasingly prescribed to patients...Read More... The post EASD 2018: the struggle...

Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis

Anti-NMDA receptor encephalitis (ANRE) is a potentially lethal disease attributed to auto-antibodies against the N-methyl-D-aspartate receptor (NMDAR). Full recovery is possible if therapy is initiate...

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Teveten [Abbott Laboratories]

TEVETEN (eprosartan mesylate) 400mg 600mg

Blocadren(timolol maleate)tablets [Merck & Co., Inc.]

BLOCADREN(TIMOLOL MALEATE)TABLETS

Teveten hct [Abbott Laboratories]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Teveten hct [Physicians Total Care, Inc.]

TEVETEN HCT (eprosartan mesylate/hydrochlorothiazide)600/12.5mg 600/25mg

Diovan [Novartis Pharmaceuticals Corporation]

Diovan

PubMed Articles [1407 Associated PubMed Articles listed on BioPortfolio]

Antithrombotic P2Y receptor antagonists: recent developments in drug discovery.

The P2Y receptor is one of eight known P2Y receptor subtypes, and belongs to the G-protein-coupled receptor (GPCR) family. The P2Y receptor is highly expressed on blood platelets and in the brain. Pot...

Finding a ribophagy receptor.

Although ribophagy was demonstrated in budding yeast a decade ago, a specific receptor for this process has been unknown. Recently, a study revealed that NUFIP1 (nuclear FMR1 interacting protein 1) fu...

Emerging strategies targeting cb cannabinoid receptor: biased agonism and allosterism.

During these last years, the CB cannabinoid receptor has emerged as a potential anti-inflammatory target in diseases such as multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, is...

Progesterone receptor is responsible for the benign biology of skull base meningioma.

Many studies have been performed to evaluate the roles of estrogen receptor (ER) and progesterone receptor (PGR) in meningiomas, but their influence on tumor behavior remains unclear.

NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.

Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand of a Gi protein-coupled receptor named NOP. Both N/OFQ and NOP receptor are widely expressed in brain areas involved in the control of emotional...

Clinical Trials [2037 Associated Clinical Trials listed on BioPortfolio]

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Anti-NMDA receptor encephalitis is the most common curable non-infectious autoimmune encephalitis,but because of the lack of recognition in the clinic, usually been misdiagnosed as other...

The Effect of GIP(3-30)NH2

Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor antagonist and evaluation of effect of insulin secretion in healthy subjects.

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

Delinieation of GIP's effects during an oral glucose tolerance test (OGTT) in humans using GIP receptor antagonisation.

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

The investigators' proposed phase 2 clinical trial will be an open-label, non-randomized study among 80 women with metastatic breast cancer. The study treatment period will be up to twelve...

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

We would like to evaluate the changes in nerve innervation and TRPV1 receptor expression along with microscopic changes associated with heart burn and abdominal pain

Companies [152 Associated Companies listed on BioPortfolio]

Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Receptor BioLogix, Inc.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of prot...

Florida Biologix

Florida Biologix® is a Phase I/II biologics contract development, manufacturing and testing organization that offers a range of biopharmaceutical services to the biotech...

Millenium Biologix Corporation

Millenium Biologix Corporation is a leading biomedical company, developing and supplying innovative products for Regenerative Medicine in the field of skeletal disease and trauma, covering clinical an...

Millenium Biologix Incorporated

Millenium Biologix Inc. is a medical biotechnology company specializing in the commercialization of innovative products based on a proprietary synthetic bone technology. These advanced BioBone product...

More Information about "Receptor BioLogix, Inc." on BioPortfolio

We have published hundreds of Receptor BioLogix, Inc. news stories on BioPortfolio along with dozens of Receptor BioLogix, Inc. Clinical Trials and PubMed Articles about Receptor BioLogix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Receptor BioLogix, Inc. Companies in our database. You can also find out about relevant Receptor BioLogix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record